HOME | CONTACT US

Welcome to the IDS Web Site...

The Immunology of Diabetes Society is an
international collaborative initiative set up to
advance research related to the etiology,
pathogenesis, prevention and cure of
type 1 diabetes.

12th International Congress of the
Immunology of Diabetes Society

[Photos from 12th IDS]

13th International Congress of the Immunology of Diabetes Society will be held in Melbourne, Australia between December 7 to 11, 2013.

For more information Visit : www.ids2013.org

2nd Islet Autoantibody Standardization Program (IASP) proficiency evaluation -IASP 2013. Click here to more Information
To know all about the ongoing effort in the Genetics of Type 1 Diabetes.
visit the website: www.t1dgc.org

Proc Natl Acad Sci U S A. 2007 Oct 23: The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Nature. 2008 Sep 21. [Epub ahead of print]: Innate immunity and intestinal microbiota in the development of Type 1 diabetes. 2008 Sep 16. [Epub ahead of print]: Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice Clin Immunol. Lancet. 2008 Sep 25. [Epub ahead of print]: Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Diabetes. 2008 Oct;57(10):2555-62.: The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Lancet. 2008 Sep 22. [Epub ahead of print]: Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. J Clin Invest. 2008 Oct;118(10):3268-71: Novel epitope begets a novel pathway in type 1 diabetes progression. J Clin Invest. 2008 Oct 1;118(10):3390-3402: CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. N Engl J Med. 2008 Oct 2;359(14):1464-76: Continuous glucose monitoring and intensive treatment of type 1 diabetes.